Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): A methodological approach to assess consistencies across databases from the PROTECT-EU project

Pharmacoepidemiology and Drug Safety

Volumn 25, Issue , 2016, Pages 66-78

  Requena, Gema ^a   Huerta, Consuelo ^b   Gardarsdottir, Helga ^c,d   Logie, John ^e   González González, Rocío ^b   Abbing Karahagopian, Victoria ^c   Miret, Montserrat ^f   Schneider, Cornelia ^g   Souverein, Patrick C ^c   Webb, Dave ^e   Afonso, Ana ^c   Boudiaf, Nada ^e   Martin, Elisa ^b   Oliva, Belén ^b   Alvarez, Arturo ^b   De Groot, Mark C H ^c   Bate, Andrew ^h   Johansson, Saga ⁱ   Schlienger, Raymond ^j   Reynolds, Robert ^k   Klungel, Olaf H ^d   de Abajo, Francisco J ^a,l   more..

^a UNIVERSITY OF ALCALÁ   (Spain)

^b Parque Empresarial Las Mercedes   (Spain)

^c UTRECHT UNIVERSITY   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e GLAXOSMITHKLINE   (United Kingdom)

^f MERCK KGAA   (Germany)

^g UNIVERSITY OF BASEL   (Switzerland)

^h PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

ⁱ ASTRAZENECA R AND D   (Sweden)

^j NOVARTIS PHARMA AG   (Switzerland)

^k PFIZER INC   (United States)

^l HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

more..

Author keywords

Benzodiazepines; Cohort; Databases; Hip fractures; Nested case control; Pharmacoepidemiology

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; HYPNOTIC AGENT; HYPNOTIC SEDATIVE AGENT;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; DATA BASE; DRUG SAFETY; EUROPEAN; FEMALE; FEMUR FRACTURE; HAZARD RATIO; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; ODDS RATIO; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT DURATION; VERY ELDERLY; ADOLESCENT; EUROPEAN UNION; FACTUAL DATABASE; HIP FRACTURES; STANDARDS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; CASE-CONTROL STUDIES; COHORT STUDIES; DATABASES, FACTUAL; EUROPEAN UNION; FEMALE; HIP FRACTURES; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED;

EID: 84932183299     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3816     Document Type: Article

References (37)

1. Takahashi Y, Nishida Y, Asai S. Utilization of health care databases for pharmacoepidemiology. Eur J Clin Pharmacol. 2012 Feb; 68(2): 123-129. PubMed PMID: 21808989.
2. Cardwell CR, Abnet CC, Veal P, Hughes CM, Cantwell MM, Murray LJ. Exposure to oral bisphosphonates and risk of cancer. Int J cancer. 2012 Sep 1; 131(5): E717-E725. PubMed PMID: 22161552. Pubmed Central PMCID: 3517893 2012.
3. Green J, Czanner G, Reeves G, Watson J, Wise L, Beral V. Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort. BMJ 2010; 341: c4444. PubMed PMID: 20813820. Pubmed Central PMCID: 2933354.
4. Meier CR, Schlienger RG, Kraenzlin ME, Schlegel B, Jick H. HMG-CoA reductase inhibitors and the risk of fractures. JAMA. 2000 Jun 28; 283(24): 3205-3210. PubMed PMID: 10866867. Epub 2000/06/24. eng.
5. van Staa TP, Wegman S, de Vries F, Leufkens B, Cooper C. Use of statins and risk of fractures. JAMA. 2001 Apr 11; 285(14): 1850-1855. PubMed PMID: 11308398.
6. Wagner AK, Zhang F, Soumerai SB, et al. Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? Arch Intern Med. 2004 Jul 26; 164(14): 1567-1572. PubMed PMID: 15277291. Epub 2004/07/28. eng.
7. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995 Mar 23; 332(12): 767-773. PubMed PMID: 7862179. Epub 1995/03/23. eng.
8. Guo Z, Wills P, Viitanen M, Fastbom J, Winblad B. Cognitive impairment, drug use, and the risk of hip fracture in persons over 75years old: a community-based prospective study. Am J Epidemiol. 1998 Nov 1; 148(9): 887-892. PubMed PMID: 9801019.
9. Jacqmin-Gadda H, Fourrier A, Commenges D, Dartigues JF. Risk factors for fractures in the elderly. Epidemiology. 1998 Jul; 9(4): 417-423. PubMed PMID: 9647906.
10. Xing D, Ma XL, Ma JX, Wang J, Yang Y, Chen Y. Association between use of benzodiazepines and risk of fractures: a meta-analysis. Osteoporos Int. 2014 Jan; 25(1): 105-120. PubMed PMID: 24013517.
11. Khong TP, de Vries F, Goldenberg JS, et al. Potential impact of benzodiazepine use on the rate of hip fractures in five large European countries and the United States. Calcif Tissue Int. 2012 Jul; 91(1): 24-31. PubMed PMID: 22566242. Pubmed Central PMCID: 3382650. Epub 2012/05/09. eng.
12. Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta-analyses. BMJ 2011; 342: d549. PubMed PMID: 21310794.
13. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003 Sep 6; 327(7414): 557-560. PubMed PMID: 12958120. Pubmed Central PMCID: 192859.
14. Madigan D, Ryan PB, Schuemie M, et al. Evaluating the impact of database heterogeneity on observational study results. Am J Epidemiol. 2013 Aug 15; 178(4): 645-651. PubMed PMID: 23648805. Pubmed Central PMCID: 3736754.
15. European Network of Centres for Pharmacoepidemiology and Pharmacovigilance ENCePP. [Oct 2014]. Available from: http://www.encepp.eu/encepp/studySearch.htm
16. Abbing-Karahagopian V, Kurz X, de Vries F, et al. Abstracts: bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project. Curr Clin Pharmacol. 2014 May; 9(2): 130-138.
17. WHO Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) Classification System. [Cited 2014 September]; [Last updated: 2013-12-19];Available from: http://www.whocc.no/atc_ddd_index/.
18. Finkle WD, Der JS, Greenland S, et al. Risk of fractures requiring hospitalization after an initial prescription of zolpidem, alprazolam, lorazepam, or diazepam in older adults. J Am Geriatr Soc 2011; 59: 1883-1890.
19. Gardarsdottir H, Souverein PC, Egberts TC, Heerdink ER. Construction of drug treatment episodes from drug-dispensing histories is influenced by the gap length. J Clin Epidemiol. 2010 Apr 63(4): 422-427. PubMed PMID: 19880282. Epub 2009/11/03. eng.
20. Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA. 1989 Dec 15; 262(23): 3303-3307. PubMed PMID: 2573741. Epub 1989/12/15. eng.
21. Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ, 3rd. Psychotropic drug use and the risk of hip fracture. N Engl J Med. 1987 Feb 12; 316(7): 363-369. PubMed PMID: 2880292. Epub 1987/02/12. eng.
22. Huang AR, Mallet L, Rochefort CM, Eguale T, Buckeridge DL, Tamblyn R. Medication-related falls in the elderly: causative factors and preventive strategies. Drugs Aging. 2012 May 1; 29(5): 359-376. PubMed PMID: 22550966.
23. Ensrud KE, Blackwell T, Mangione CM, et al. Central nervous system active medications and risk for fractures in older women. Arch Intern Med. 2003 Apr 28; 163(8): 949-957. PubMed PMID: 12719205. Epub 2003/04/30. eng.
24. Kanis J. Assessment of osteoporosis at the primary health care level: on behalf of the World Health Organization Scientific Group (WHO); 2007 [Nov 2012]. Available from: http://www.shef.ac.uk/FRAX/pdfs/WHO_Technical_Report.pdf.
25. Tebe C, del Rio LM, Casas L, et al. Risk factors for fragility fractures in a cohort of Spanish women. Gac Sanit. 2011 Nov-Dec; 25(6): 507-512. PubMed PMID: 21955641. Epub 2011/10/01. Factores de riesgo de fracturas por fragilidad en una cohorte de mujeres espanolas. spa.
26. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986 Sep; 7(3): 177-188. PubMed PMID: 3802833.
27. Zint K, Haefeli WE, Glynn RJ, Mogun H, Avorn J, Sturmer T. Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults. Pharmacoepidemiol Drug Saf. 2010 Dec; 19(12): 1248-1255. PubMed PMID: 20931664.
28. Requena G, Logie J, Martín E, et al. Do case-only designs yield consistent results across design and different databases? A case study of hip fractures and benzodiazepines. Pharmacoepidemiol Drug Saf. 2016; 25(Suppl. 1): 79-87.
29. Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J. Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry. Jun 2001; 158(6): 892-898.
30. Chang CM, Wu EC, Chang IS, Lin KM. Benzodiazepine and risk of hip fractures in older people: a nested case-control study in Taiwan. Am J Psychiatry. 2008 Aug; 16(8): 686-692. PubMed PMID: 18669947. Epub 2008/08/02. eng.
31. Ashton PCH. Guidelines for the rational use of benzodiazepines 2000 [26/07/2012]. Available from: http://www.benzo.org.uk/asgr.htm.
32. van der Hooft CS, Schoofs MW, Ziere G, et al. Inappropriate benzodiazepine use in older adults and the risk of fracture. Br J Clin Pharmacol. 2008 Aug; 66(2): 276-282. PubMed PMID: 18460035. Pubmed Central PMCID: 2492915.
33. Huerta C, Abbing-Karahagopian V, Requena G, et al. Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project. Submitted to Pharmacoepidemiology and Drug Safety. Accepted for publication, PDS-14-0405.R2 2015.
34. Requena G, Abbing-Karahagopian V, Huerta C, et al. Incidence rates and trends of hip/femur fractures in five European countries: comparison using e-healthcare records databases. Calcif Tissue Int. 2014 Jun; 94(6):580-589. doi: 10.1007/s00223-014-9850-y. Epub 2014 Apr 1. PMID: 24687523.
35. Abbing-Karahagopian V, Souverein PC, Martin E, et al. Understanding inconsistency in the results from observational pharmacoepidemiological studies: the case of antidepressant use and risk of hip fracture. Submitted to Pharmacoepidemiology and Drug Safety. Under review. PDS-14-0413 2014.
36. Rücker G, Schwarzer G, Carpenter JR, Schumacher M. Undue reliance on I(2) in assessing heterogeneity may mislead. BMC Med Res Methodol 2008 Nov 27; 8: 79. doi:10.1186/1471-2288-8-79. PubMed PMID: 19036172; PubMed Central PMCID: PMC2648991.
37. Higgins J, Thompson S, Deeks J, Altman D. Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J Health Serv Res Policy. 2002 Jan; 7(1): 51-61. Review. PubMed PMID:11822262.